CANY
ITOS

Caxton Associates (New York)’s iTeos Therapeutics ITOS Stock Holding History

Caxton Associates (New York)’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30,695
Closed -$418K – 570
2023
Q1 		$418K Buy
+30,695
New +$418K 0.06% 292